Fernö M - Search Results

1

Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.

Grabau D, Dihge L, Fernö M, Ingvar C, Rydén L. Grabau D, et al. Among authors: ferno m. Eur J Surg Oncol. 2013 Jun;39(6):601-7. doi: 10.1016/j.ejso.2013.03.012. Epub 2013 Apr 8. Eur J Surg Oncol. 2013. PMID: 23579175

2

Estrogen receptor and binding site for estramustine in metastatic malignant melanoma.

Fernö M, Borg A, Ingvar C, Jönsson PE. Fernö M, et al. Anticancer Res. 1987 Jul-Aug;7(4B):741-3. Anticancer Res. 1987. PMID: 3314674

3

Phase II study of estramustine phosphate (Estracyt) in patients with metastatic melanoma.

Jönsson PE, Ingvar C, Fernö M, Hafström L, Rudenstam CM. Jönsson PE, et al. Among authors: ferno m. Eur J Cancer Clin Oncol. 1988 Mar;24(3):413-5. doi: 10.1016/s0277-5379(98)90010-4. Eur J Cancer Clin Oncol. 1988. PMID: 3383944

4

Prognostic factors in breast cancer: a brief review.

Fernö M. Fernö M. Anticancer Res. 1998 May-Jun;18(3C):2167-71. Anticancer Res. 1998. PMID: 9703779 Review.

5

Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.

Ringberg A, Idvall I, Fernö M, Anderson H, Anagnostaki L, Boiesen P, Bondesson L, Holm E, Johansson S, Lindholm K, Ljungberg O, Ostberg G. Ringberg A, et al. Among authors: ferno m. Eur J Surg Oncol. 2000 Aug;26(5):444-51. doi: 10.1053/ejso.1999.0919. Eur J Surg Oncol. 2000. PMID: 11016463

6

Histopathological and cell biological factors of ductal carcinoma in situ before and after the introduction of mammographic screening.

Idvall I, Andersson C, Fallenius G, Ingvar C, Ringberg A, Strand C, Akerman M, Fernö M. Idvall I, et al. Among authors: ferno m. Acta Oncol. 2001;40(5):653-9. doi: 10.1080/028418601750444222. Acta Oncol. 2001. PMID: 11669340

7

Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial.

Jirström K, Rydén L, Anagnostaki L, Nordenskjöld B, Stål O, Thorstenson S, Chebil G, Jönsson PE, Fernö M, Landberg G. Jirström K, et al. Among authors: ferno m. J Clin Pathol. 2005 Nov;58(11):1135-42. doi: 10.1136/jcp.2005.027185. J Clin Pathol. 2005. PMID: 16254100 Free PMC article. Clinical Trial.

8

Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.

Berglund P, Stighall M, Jirström K, Rydén L, Fernö M, Nordenskjöld B, Landberg G. Berglund P, et al. Among authors: ferno m. J Clin Pathol. 2008 Feb;61(2):184-91. doi: 10.1136/jcp.2007.047688. Epub 2007 May 4. J Clin Pathol. 2008. PMID: 17483245 Clinical Trial.

9

AIB1 is a predictive factor for tamoxifen response in premenopausal women.

Alkner S, Bendahl PO, Grabau D, Lövgren K, Stål O, Rydén L, Fernö M; South Swedish and South-East Swedish Breast Cancer Groups. Alkner S, et al. Among authors: ferno m. Ann Oncol. 2010 Feb;21(2):238-244. doi: 10.1093/annonc/mdp293. Epub 2009 Jul 23. Ann Oncol. 2010. PMID: 19628566 Free article. Clinical Trial.

10

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

Niméus-Malmström E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F, Blomqvist C, Fernö M, Fjällskog ML. Niméus-Malmström E, et al. Among authors: ferno m. Int J Cancer. 2010 Aug 15;127(4):961-7. doi: 10.1002/ijc.25091. Int J Cancer. 2010. PMID: 19957331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters